Recent studies demonstrate that survivin expression is reduced in preeclampsia and IUGR, correlating with increased trophoblast apoptosis and invasive defects, while overexpression is seen in gestational trophoblastic disease [13]. Here, BIRC5 is linked to fetal growth restriction.